Calliditas Therapeutics
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
CALTX | ST
Overview
Corporate Details
- ISIN(s):
- SE0010441584 (+1 more)
- LEI:
- 549300PVPZO8TNT76B58
- Country:
- Sweden
- Address:
- Box 70351, 107 24 Stockholm
- Website:
- https://www.calliditas.se/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Calliditas Therapeutics is a commercial-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for rare diseases (orphan indications) with significant unmet medical needs. The company's pipeline has an initial focus on renal and hepatic diseases. Its lead product, TARPEYO® (budesonide) in the U.S. and marketed as Kinpeygo® in Europe, is a novel therapeutic developed to treat primary IgA nephropathy (IgAN). Calliditas leverages its scientific and commercial expertise and seeks strategic partnerships to advance the development and global commercialization of its therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-09-16 15:30 |
Delisting Announcement
Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm
|
English | 134.8 KB | ||
| 2024-09-16 15:30 |
Delisting Announcement
Avnotering av Calliditas Therapeutics AB (publ) från Nasdaq Stockholm
|
Swedish | 134.6 KB | ||
| 2024-08-13 07:00 |
Interim Report
|
Swedish | 2.0 MB | ||
| 2024-08-13 07:00 |
Interim Report
|
English | 2.0 MB | ||
| 2024-08-06 11:00 |
Major Shareholding Notification
|
English | 34.7 KB | ||
| 2024-08-05 13:51 |
Major Shareholding Notification
|
English | 34.5 KB | ||
| 2024-07-31 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Calliditas Therapeutics
|
Swedish | 180.0 KB | ||
| 2024-07-31 14:00 |
Share Issue/Capital Change
Number of shares and votes in Calliditas Therapeutics
|
English | 120.7 KB | ||
| 2024-07-26 08:00 |
Earnings Release
Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliar…
|
English | 219.4 KB | ||
| 2024-07-26 08:00 |
Regulatory News Service
Calliditas utläser positiva topline-data från fas 2b-studien TRANSFORM i primär…
|
Swedish | 223.3 KB | ||
| 2024-06-17 17:30 |
Post-Annual General Meeting Information
Kommuniké från årsstämman i Calliditas Therapeutics AB (publ)
|
Swedish | 158.0 KB | ||
| 2024-06-17 17:30 |
Post-Annual General Meeting Information
Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)
|
English | 141.0 KB | ||
| 2024-06-04 10:15 |
Major Shareholding Notification
|
English | 34.1 KB | ||
| 2024-05-30 20:00 |
Legal Proceedings Report
Calliditas partner STADA får positivt yttrande från CHMP som rekommenderar ett …
|
Swedish | 176.3 KB | ||
| 2024-05-30 20:00 |
Legal Proceedings Report
Calliditas partner STADA receives positive CHMP opinion recommending full appro…
|
English | 177.8 KB |
Automate Your Workflow. Get a real-time feed of all Calliditas Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Calliditas Therapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Calliditas Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-23 | Diane Parks | Other | Other | 4,086 | N/A |
| 2024-07-04 | Fredrik Johansson | Other | Sell | 36,000 | 7,408,800.00 SEK |
| 2024-07-04 | Fredrik Johansson | Other | Sell | 31,439 | 6,476,434.00 SEK |
| 2024-07-04 | Fredrik Johansson | Other | Buy | 40,939 | N/A |
| 2024-07-03 | Frank Bringstrup | Other | Sell | 8,000 | 1,646,400.00 SEK |
| 2024-07-02 | Richard Philipson | Other | Sell | 27,209 | 5,591,177.41 SEK |
| 2024-07-02 | Frank Bringstrup | Other | Sell | 9,796 | 2,012,980.04 SEK |
| 2024-07-02 | Sandra Boström Frithiof | Other | Sell | 6,530 | 1,341,849.70 SEK |
| 2024-07-01 | Richard Philipson | Other | Sell | 23,676 | 4,866,838.56 SEK |
| 2024-07-01 | Frank Bringstrup | Other | Sell | 8,523 | 1,751,987.88 SEK |
Peer Companies
